Core Laboratories N.V. (CLB) Holdings Increased by Fjarde AP Fonden Fourth Swedish National Pension Fund
Fjarde AP Fonden Fourth Swedish National Pension Fund grew its holdings in Core Laboratories N.V. (NYSE:CLB) by 27.4% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 19,245 shares of the oil and gas company’s stock after purchasing an additional 4,140 shares during the period. Fjarde AP Fonden Fourth Swedish National Pension Fund’s holdings in Core Laboratories N.V. were worth $1,949,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds have also added to or reduced their stakes in the business. Airain ltd purchased a new stake in Core Laboratories N.V. in the second quarter worth $235,000. Andra AP fonden purchased a new stake in Core Laboratories N.V. in the second quarter worth $810,000. Robeco Institutional Asset Management B.V. purchased a new stake in Core Laboratories N.V. in the second quarter worth $1,250,000. Intrust Bank NA increased its stake in Core Laboratories N.V. by 32.7% in the second quarter. Intrust Bank NA now owns 4,366 shares of the oil and gas company’s stock worth $442,000 after purchasing an additional 1,075 shares during the period. Finally, Parallel Advisors LLC increased its stake in Core Laboratories N.V. by 13.1% in the second quarter. Parallel Advisors LLC now owns 1,008 shares of the oil and gas company’s stock worth $101,000 after purchasing an additional 117 shares during the period.
Core Laboratories N.V. (CLB) opened at 89.59 on Monday. The firm has a 50-day moving average price of $96.43 and a 200 day moving average price of $105.73. Core Laboratories N.V. has a 1-year low of $86.55 and a 1-year high of $125.83. The stock has a market cap of $3.95 billion, a price-to-earnings ratio of 54.96 and a beta of 1.60.
Core Laboratories N.V. (NYSE:CLB) last issued its quarterly earnings results on Monday, July 24th. The oil and gas company reported $0.52 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.51 by $0.01. Core Laboratories N.V. had a return on equity of 49.29% and a net margin of 11.80%. The company had revenue of $163.90 million for the quarter, compared to the consensus estimate of $168.23 million. During the same quarter in the prior year, the business earned $0.35 EPS. Core Laboratories N.V.’s revenue was up 10.7% on a year-over-year basis. On average, equities research analysts anticipate that Core Laboratories N.V. will post $2.09 EPS for the current fiscal year.
The business also recently declared a quarterly dividend, which was paid on Monday, August 14th. Shareholders of record on Monday, July 17th were issued a dividend of $0.55 per share. The ex-dividend date was Thursday, July 13th. This represents a $2.20 annualized dividend and a yield of 2.46%. Core Laboratories N.V.’s dividend payout ratio (DPR) is 134.15%.
CLB has been the topic of a number of recent analyst reports. Zacks Investment Research lowered Core Laboratories N.V. from a “buy” rating to a “hold” rating in a research note on Friday, June 23rd. Credit Suisse Group upgraded Core Laboratories N.V. from a “neutral” rating to an “outperform” rating and set a $110.00 price target on the stock in a research note on Thursday, August 24th. They noted that the move was a valuation call. BidaskClub upgraded Core Laboratories N.V. from a “sell” rating to a “hold” rating in a research note on Wednesday, July 5th. Cowen and Company restated a “hold” rating and set a $100.00 price target on shares of Core Laboratories N.V. in a research note on Friday. Finally, ValuEngine lowered Core Laboratories N.V. from a “hold” rating to a “sell” rating in a research note on Friday. Four investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and five have issued a buy rating to the company. The company currently has a consensus rating of “Hold” and an average price target of $113.83.
TRADEMARK VIOLATION WARNING: “Core Laboratories N.V. (CLB) Holdings Increased by Fjarde AP Fonden Fourth Swedish National Pension Fund” was published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this report on another domain, it was copied illegally and reposted in violation of US & international copyright & trademark legislation. The legal version of this report can be accessed at https://www.thecerbatgem.com/2017/09/04/core-laboratories-n-v-clb-holdings-increased-by-fjarde-ap-fonden-fourth-swedish-national-pension-fund.html.
Core Laboratories N.V. Company Profile
Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples.
Receive News & Stock Ratings for Core Laboratories N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories N.V. and related stocks with our FREE daily email newsletter.